Article
Adverse event analysis and signal detection of calcitonin gene-related peptide inhibitors using the FDA Adverse Event Reporting System database
2024-07-19
Abstract excerpt
<title>Abstract</title> <p>Background Calcitonin gene-related peptide (CGRP) inhibitors have been FDA-approved for migraine prophylaxis and relief. However, their safety profile remains uncertain. This study analyzes adverse events (AEs) and signals of disproportionate reporting (SDRs) using the FDA Adverse Event Reporting System (FAERS). Methods We examined AEs reported to FAERS from the approval date to Augus...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- daab0b83-8f6e-50e0-965b-56953ad1451f
- DOI
- 10.21203/rs.3.rs-4628990/v1
